Monte Rosa Therapeutics, Inc.
GLUENasdaqCIK 1826457HealthcareFiscal year ends Dec 31
Reports and events: 93 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0111:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-409833 |
| 2026-09-0811:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-384360 |
| 2026-08-0611:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336711 |
| 2026-08-0611:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336681 |
| 2026-07-0621:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000558 |
| 2026-06-1120:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267465 |
| 2026-05-0711:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210358 |
| 2026-05-0711:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210298 |
| 2026-04-2920:01 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001193125-26-191439 |
| 2026-03-1920:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000294 |
| 2026-03-1711:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-109360 |
| 2026-03-1711:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-109353 |
| 2026-02-1021:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-044616 |
| 2026-01-0921:32 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009005 |
| 2026-01-0921:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-008951 |
| 2026-01-0721:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006341 |
| 2026-01-0712:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-005420 |
| 2025-12-1612:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319981 |
| 2025-11-1221:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-277603 |
| 2025-11-0612:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268045 |
| 2025-11-0612:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-268042 |
| 2025-09-1511:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-202760 |
| 2025-08-0711:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104550 |
| 2025-08-0711:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104545 |
| 2025-06-1320:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-086129 |
| 2025-05-0811:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066372 |
| 2025-05-0811:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066370 |
| 2025-04-2520:01 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0000950170-25-058686 |
| 2025-03-2013:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-042344 |
| 2025-03-2011:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-042319 |
| 2025-01-1012:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-003776 |
| 2024-12-1312:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-136042 |
| 2024-12-0512:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-133525 |
| 2024-11-0712:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122780 |
| 2024-11-0712:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122766 |
| 2024-10-3021:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-247656 |
| 2024-10-2810:59 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-117567 |
| 2024-09-2421:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-224875 |
| 2024-08-1223:46 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000618 |
| 2024-08-1221:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-198980 |
| 2024-08-0811:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093296 |
| 2024-08-0811:02 ET | 8-K | 2.02 Results of operations | 0000950170-24-093294 |
| 2024-06-2711:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-078159 |
| 2024-06-1220:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-072407 |
| 2024-05-3011:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-149802 |
| 2024-05-1620:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-140533 |
| 2024-05-1300:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000471 |
| 2024-05-0911:45 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056288 |
| 2024-05-0911:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056253 |
| 2024-05-0220:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-052055 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.